Navigation Links
Sexual issues a major concern for cancer patients taking new targeted drugs
Date:10/12/2010

New drugs that target specific molecular mechanisms of cancer have improved the treatment of cancer patients in recent years, but those benefits may come with a cost to the patient's sex life, researchers have found.

At the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy, French researchers reported on one of the few studies to investigate the impact of cancer therapy on the sexual functioning of patients.

Dr Yohann Loriot and Dr Thomas Bessede from Institut Gustave Roussy in Villejuif, France and colleagues found that patients taking targeted therapies had significantly decreased levels of sexual function and satisfaction.

"The new molecular targeted therapies have been available for 6 or 7 years and researchers and physicians have observed some new side-effects not often reported with chemotherapy such as cutaneous side-effects and gastro-intestinal toxicity. But very few studies have been conducted in the field of sexuality, mainly because patients are not willing to talk with their physicians on this topic," Dr Loriot said.

The researchers surveyed 51 patients (40 men and 11 women) who had been taking molecular targeted therapies for more than three months without progressive disease about changes in their sexual life.

The drugs involved were sunitinib, sorafenib, temsirolimus, everolimus, bevacizumab, tarceva and cetuximab. Men completed the International Index of Erectile Function (IEEF) questionnaire --which includes questions on erectile function, intercourse satisfaction, orgasmic function, sexual desire and overall satisfaction.

Women in the study completed the Female Sexual Function Index (FSFI) questionnaire, which includes questions on desire, arousal, lubrication, orgasm, satisfaction and pain.

The median overall IIEF score for men was 40, just 53% of the maximum score. For women, the median FSFI score was 8.4, just 24% of the maximum.

"
'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority
2. New research shows emotional impact of low sexual desire and associated distress
3. Are Latino teens sexual risk takers? Its complicated, researcher says
4. New study reveals prevalence of cyberbullying and its psychological impact on nonheterosexual youth
5. Researcher presents risk-free treatment for low female sexual desire
6. Tumor surgery impairs sexuality
7. Why do sexually experienced girls resume sexual activity after abstinence?
8. Sexual Desire, Satisfaction Dont Diminish During Pregnancy
9. Study points out risks of nonromantic sexual relationships
10. Helping fathers of sexually abused children
11. JustGetTested.com Recommends Confidential Blood Testing During Sexually Transmitted Disease (STD) Awareness Month (April)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... (HealthDay News) -- When it comes to firearm deaths, ... States, while the District of Columbia has the highest, ... deaths from gun-related violence -- including murders, suicides and ... the study revealed. Hawaii,s rate was roughly three per ... the District of Columbia had the highest rate of ...
(Date:9/19/2014)... led by Medical College of Wisconsin (MCW) scientists has identified ... in rats, mice and in humans. The findings are published ... , Leah Solberg Woods, Ph.D., associate professor of pediatrics ... Wisconsin Research Institute, led the study and is the corresponding ... identified a gene called Tpcn2 in which a variant was ...
(Date:9/19/2014)... Top10BestSEOHosting.com today compares many professional Windows ... and Bluehost are the best suppliers of 2014. ... hosting (including VPS and cloud hosting) at affordable ... information. , HostMonster ( http://www.hostmonster.com/track/seohosts ) helps business ... fraction of the cost. As a top rated ...
(Date:9/19/2014)... patients with advanced, incurable cancer do not receive any ... this month at the ESMO 2014 Congress in Madrid, ... come at the same time as 15 new oncology ... being awarded the prestigious title of ,ESMO Designated Centre ... Dr Alexandru Grigorescu, medical oncology consultant at the Institute ...
(Date:9/19/2014)... 2014 Follow us on ... for detection and quantification of the presence of ... by steady expansion in immunodiagnostics and technological advancements ... systems market has evolved remarkably well over the ... diabetes, cardio-vascular ailments, infectious diseases, allergy and cancer, ...
Breaking Medicine News(10 mins):Health News:U.S. Gun Deaths Lowest in Hawaii, Highest in D.C. 2Health News:Top10BestSEOHosting.com: They Are Best Windows Web Hosting Suppliers Of 2014 2Health News:Patients with advanced, incurable cancer denied palliative care 2Health News:Patients with advanced, incurable cancer denied palliative care 3Health News:Patients with advanced, incurable cancer denied palliative care 4Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 4
... By Amanda Gardner HealthDay Reporter , ... that derives fats and proteins from vegetable sources rather ... Comparing the two types of diets over two decades, ... reduced rates of death from cardiovascular disease and cancer, ...
... States must focus on conserving the use of antibacterial ... rising rates of antibiotic-resistant infections, according to an analysis ... of antibiotics is being depleted by resistance, which occurs ... no longer respond to widely-used treatments. Most proposals to ...
... The Endocrine Society released a new clinical practice guideline ... (CAH). The guideline features a series of evidence-based clinical ... guideline, published in the September 2010 issue of the ... JCEM ), a publication of The Endocrine Society, is ...
... methods, researchers at the University of California, San Diego ... spend significantly more time visually examining dynamic geometric patterns ... viewing pattern not found in either typical or developmentally ... that a preference for geometric patterns early in life ...
... psychotic disorders and living in urban areas appears to ... cities, according to a report in the September issue ... the JAMA/Archives journals. "There is a ... authors write as background in the article. "The clearest ...
... blood levels of chemicals used in the production of ... have elevated total and LDL cholesterol levels, according to ... of Pediatrics & Adolescent Medicine , one of the ... compounds known as perfluoroalkyl acidsincluding perfluorooctanoic acid (PFOA) and ...
Cached Medicine News:Health News:Low-Carb Diets Heavy on Meat May Raise Health Risks 2Health News:Pharmaceutical conservation key to slowing rise of antibiotic-resistant infections 2Health News:Pharmaceutical conservation key to slowing rise of antibiotic-resistant infections 3Health News:Experts recommend universal screening of newborns for congenital adrenal hyperplasia 2Health News:Visual pattern preference may be indicator of autism in toddlers 2Health News:Visual pattern preference may be indicator of autism in toddlers 3Health News:Study examines association between urban living and psychotic disorders 2Health News:Compounds in non-stick cookware may be associated with elevated cholesterol in children and teens 2
(Date:9/19/2014)... EASTON, Mass. , Sept. 19, 2014 /PRNewswire/ ... "Company") today announced it has received and approved ... Barozyme HT48 instruments and has begun to manufacture ... the first instrument will be ready for shipment ... be built and released at a rate of ...
(Date:9/19/2014)... 19, 2014 Aufgrund der ... äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt auch die ... verfügbar unter pharmaserialisation.com , zeigt die Serialisierungsanforderungen ... in Kraft treten. Für international tätige ... um das "ob", sondern darum, "wann" sie die ...
(Date:9/19/2014)... and CAMBRIDGE, Mass. ... Inc. (PGDx), a provider of advanced cancer ... Medicines , a leader in discovering and developing ... today disclosed the first-ever comprehensive genomic study of ... deadly cancer of the female reproductive system, also ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4
Produce clean 0.75 mm round hole without tissue tags. Serrated squeeze action handle....
Target illumination for day and night testing. Glare luminance distance. The Optec 3500 remote control offers flexible positioning during test administration. Each vision tester includes 12 tests sli...
... The CSV- lOOOHGT instrument provides standardized glare testing. ... Vectorvision test faces for the evaluation of glare ... is precisely calibrated to simulate two on-coming halogen ... feet. The glare level can be adjusted to ...
Ruler S/Steel....
Medicine Products: